Platelets in Pregnancy

Active, not recruiting

• Conditions: Hypertensive Disorder of Pregnancy

• Registration Number: NCT06194643
• Lead Sponsor: NYU Langone Health

Brief Summary

This is a prospective observational cohort study of platelet phenotype in pregnant patients at high-risk for the development preeclampsia. Blood samples will be collected prior to the initiation of daily aspirin and again in the second trimester to evaluate for platelet changes during pregnancy in patient's as a result of aspirin use and their association with adverse perinatal outcomes.

Detailed Description

Not available

Study Timeline

• Study Start: 2023-01-17
• Study First Submitted: 2023-12-22
• Study First Submitted QC: 2023-12-22
• Study First Posted: 2024-01-08
• Status Verified: 2024-10
• Last Update Submitted: 2024-10-02
• Last Update Posted: 2024-10-04
• Primary Completion: 2025-06
• Study Completion: 2025-06

Recruitment & Eligibility

• Status: ACTIVE_NOT_RECRUITING
• Sex: Female
• Target Recruitment: 66

Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Number of Individuals with Overactive Platelets	Blood Draw 2 (taken between Weeks 24 and 28)

Secondary Outcome Measures

Name	Time	Method
Incidence of Adverse Pregnancy Outcomes	Day 30 Post-Delivery (Up to Month 11)

Trial Locations

Locations (1)

NYU Langone Health; 🇺🇸 New York, New York, United States